Actionable news
All posts from Actionable news
Actionable news in HTWR: Heartware International, Inc.,

Heartware investigating adverse events in MVAD CE Mark clinical trial; restart of enrollment likely delayed past November; shares off 16% premarket

In a regulatory filing, Heartware International (NASDAQ:HTWR) discloses that the re-initiation of patient enrollment in its MVAD Ventricular Assist System CE Mark clinical trial may not happen in November as previously planned due...